Abstract. Mesenchymal stem cell (MSC)-like cells have been isolated from various types of tumor. It has previously been reported that MSCs are involved in tumorigenesis and its prognosis. The aim of the present study was to isolate and compare MSC-like cells from human gastric cancer (GC) and its metastatic deposits in ovarian tissue. MSC-like cells were isolated from human gastric cancer (hGC-MSCs) and the corresponding ovarian metastatic tissues (hGCOM-MSCs) from 40 patients. The characteristics of hGC-MSCs and hGCOM-MSCs, including their morphology, surface antigens, specific gene expression and differentiation potential, were similar to those of MSCs derived from human bone marrow (hBM-MSCs) but different from GC cells. In conclusion, the present study demonstrated that MSC-like cells could be isolated from GC tissue and its ovarian metastatic tissues. The existence of MSC-like cells in GC tissues and its ovarian metastatic tissues suggests that they may be a potential target for cancer therapy, and provides an experimental foundation for investigating their role in the initiation and progression of ovarian metastasis of GC.
Introduction
Gastric cancer (GC) is the fourth most frequently occurring cancer worldwide and the second leading cause of cancer-associated mortality (1, 2) . A 2011 analysis demonstrated that 989,600 new GC cases and 738,000 mortalities were estimated to have occurred in 2008 worldwide (3) . The occurrence of GC varies with geographical area, with the highest incidence rate of GC in East Asia, particularly in South Korea, Mongolia, Japan and China (4) . At present, no effective treatment is available for this disease and identification of early stage GC is difficult as it is often asymptotic or misdiagnosed. In addition, the prognosis of patients with advanced GC remains poor due to its high metastatic recurrence (5) and the complex molecular mechanisms underlying metastasis are not well characterized (6) . Clinical observations reveal that even following radical surgery for early GC, ~50% of patients suffer from recurrence and metastasis. Local recurrence and metastatic disease are also the main causes of mortality of patients with advanced GC. Therefore, inhibition of GC metastasis is an important therapeutic strategy. The main obstacle in treating metastatic disease is that the tumor cells of the primary and metastatic lesions have biological heterogeneity, which presents differences in antigenic properties, drug sensitivity, and the ability to invade and metastasize (7) . The prognosis of ovarian metastases, also known as Krukenberg tumors, is known to be poor. Krukenberg tumors occur in 0.3-6.7% of GC patients who undergo surgery and its incidence is significantly higher in autopsies of GC patients (33-41%) (8) . It has been reported that the incidence of Krukenberg tumors, detected during the follow-up observation period following radical gastric resection or secondary surgery, is 3-4% and has a median survival time of 12-17 months (9) . There are relatively few studies on the incidence, treatment or metastatic mechanisms of Krukenberg tumors.
Mesenchymal stem cells (MSCs), also termed mesenchymal stromal cells, belong to a category of clinically relevant cell types that have the potential to be utilized for cell-based therapies, as complicated culturing or handling techniques are not required to yield clinically useful quantities. Traditionally, MSCs are characterized as having tri-lineage potential, that is they can be induced to differentiate into three mesenchymal lineages: Osteoblasts, adipocytes and chondrocytes, but they may also potentially produce other skeletal tissue cells by culturing MSCs under defined mechanochemical conditions (10) . MSCs are characterized by the expression of cell surface markers, including CD73, CD90 and CD105, and the absence of expression of hematopoietic lineage markers (11) . There has been heightened interest in the capacity of MSCs to home and migrate into tumors (12) . The effects of MSCs within tumors are varied. The theory that MSCs promote tumor growth and metastasis has been supported from studies of angiogenesis, tumor cell survival, the immunosuppressive microenvironment, as well as maintenance of cancer stem cells (CSCs) and construction of their mesenchymal niche (13) . Nevertheless, it is important to understand the principles and mechanisms through which MSCs regulate tumor progression since these may give insight into the ways in which MSCs may be used to treat tumors. Tumors are able to disseminate systemically to initiate metastatic niches in distant target organs. These niches, composed of bone marrow-derived MSCs, provide permissive conditions for future metastases (14) . Bone marrow MSCs promote stem cell dormancy in lung cancer (15) , breast cancer (16) and prostate cancer (17) cells in a metastatic niche.
MSC-like cells have been isolated from endometrial cancer (18) , glioma (19, 20) , bone sarcoma (21) and colorectal cancer (22) . However, MSC-like cells have not yet been demonstrated in human ovarian metastases of GC. The present study identified and characterized MSC-like cells from ovarian metastases of GC. were collected and examined with strict adherence to the protocol approved by this hospital. A total of 40 fresh GC tissues and corresponding ovarian metastatic tissue of gastric origin were collected from 40 female GC patients, with ages ranging between 43 and 80 years (median, 62.5 years), who had initially undergone resection at the Hunan Provincial Cancer Hospital (Changsha, China). The specimens included: Tumor tissue, adjacent normal tissue (at least 5 cm beyond the primary tumor margin), distant normal tissue and lymph nodes. The fresh tissue specimens were collected, washed with phosphate-buffered saline (PBS), cut into 1-mm 3 -sized pieces and maintained in Dulbecco's modified Eagle's medium with low glucose (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 10% fetal bovine serum (FBS), penicillin (100 U/ml; Beijing Chemeebio Pharma-tech Co., Ltd., Beijing, China) and streptomycin (100 µg/ml; Beijing Chemeebio Pharma-tech Co., Ltd.). The tissues were subsequently incubated at 37˚C in humid air with 5% CO 2 . The medium was replaced every 3 days after the initial plating. When adherent fibroblast-like cells appeared after 10 days of culture, the attached cells were trypsinized and passaged (without dilution) into a new flask for further expansion. The cells of passage 4 were used for the experiments described. MSCs isolated from human bone marrow (hBM-MSCs) and the GC cell line BCG-823 from our institute were selected as controls and used for evaluation of the experimental results.
Materials and methods

Isolation
Growth curves. The growth curves of human gastric cancer-MSCs (hGC-MSCs), human gastric cancer ovarian metastatic tissue-MSCs (hGCOM-MSCs) and hBM-MSCs at passage 4 were seeded in 24-well plates (8,000 cells/well), followed by counting the number of cells per well on 14 successive days. The procedure was repeated three times and their growth curves were compared. Osteogenic dif ferentiation in vit ro. hG C-MSCs, hGCOM-MSCs or hBM-MSCs were seeded at 5,000 cells/cm 2 in 35 mm diameter plates and cultured in DMEM with 10% FBS, with or without osteogenic supplements (0.1 nM dexamethasone, 10 mM β-glycerophosphate, 50 mg/l ascorbic acid and 4 µg/ml basic fibroblast growth factor; Sigma-Aldrich, St. Louis, MO, USA). The medium was changed three times each week and the cells were induced for 3 weeks. At the end of induction, the cells were subjected to alkaline phosphatase (ALP) staining followed by hematoxylin counterstaining (Zhingshan Golden Bridge, Beijing, China).
Reverse transcription polymerase chain reaction (RT-PCR).
Total cellular RNA was isolated from hGC-MSCs and hGCOM-MSCs using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's instructions. A total of 1.0 µg RNA was processed for cDNA synthesis with Superscript II reverse transcriptase using Oligo-dT orimers (Toyobo Co., Ltd., Osaka, Japan). PCR was performed using 1 µg of the cDNA sample with 0.3 U Taq polymerase (CinnaGen Co., Tehran, Iran) and 200 µM dNTPs, 10 pM of each primer, reaction buffer, and MgCl 2 (Takara Bio Inc., Otsu, Japan). A total of 1 µl of this mixture was used as a template for PCR to assess mRNA expression of ALP, dentin matrix acidic phosphoprotein 1 (DMP-1), osteocalcin (OSC) and osteopontin (OPN) using the ABI PRISM 7700 instrument (Applied Biosystems; Thermo Fisher Scientific, Inc., Foster City, CA, USA) with gene-specific primers [ Table I , and described previously (23, 24) ] and the SYBR Green I (Thermo Fisher Scientific, Inc.) protocol. The PCR amplification was performed for 35 cycles, with the cycling conditions as follows: 94˚C for 30 sec, 60˚C (primer) for 30 sec, 72˚C for 30 sec, with a final extension at 72˚C for 10 min. PCR products were separated on a 1% agarose gel, stained with ethidium bromide and visualized under UV light. Relative expression ratios normalized to that of β-actin (Actb) were calculated.
Statistical analysis.
All results are expressed as the mean ± standard deviation or median (range). The normality of data distribution was assessed by the Kolmogorov-Smirnov test. Data analysis was performed using SPSS version 16.0 (SPSS, Inc., Chicago, IL, USA). Receiver operating characteristic (ROC) curves were generated to determine the areas under the ROC curves and their 95% confidence intervals were calculated. A univariate test was used to examine the effect of each clinical variable on survival. Student's t-test was applied to determine statistical significance. P﹤0.05 was considered to indicate a statistically significant difference.
Results
Morphology of hGC-MSCs and hGCOM-MSCs.
The first plastic-adherent cells were detected 1 week after tissue preparation. Primary cell cultures began to form colonies after 10 days of primary culture and reached a confluence of 90-95% at day 30 (Fig. 1A) . Cells from human GC tissues and its ovarian metastatic tissues were seeded at low density on a 6-well plate and allowed to grow until 80% confluence. Cells were passaged at the same cell density. (6, 25, 26) . The hGC-MSCs at passage 4 expressed high levels of CD73 (78.58%), CD90 (74.55%) and CD105 (77.15%). However, they were negative for the hematopoietic marker CD34 (0.74%), CD45 (0.18%) and HLA-DR (0.20%). 
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The hGCOM-MSCs at passage 4 also expressed high levels of CD73 (83.24%), CD90 (76.32%) and CD105 (82.64%), but were negative for the hematopoietic markers CD34 (0.87%), CD45 (0.66%) and HLA-DR (0.53%), indicating the mesenchymal lineage of these cells (Fig. 2) . Taken together, these results demonstrated that cells isolated from human GC tissues and their ovarian metastatic tissues possess the characteristics of MSC with regards to the expression of markers. RT-PCR results demonstrated that stem cell-associated genes, including Snail, Bmi-1, ABCG2 and Nanog, and mesenchymal lineage-associated genes, including α-SMA, CD73, CD44 and β-actin, were all expressed in hBM-MSCs, hGC-MSCs and hGCOM-MSCs (Fig. 3) .
Animal studies. hGC-MSCs and hGCMO-MSCs failed to form tumors in NOD/SCID mice after >2 weeks (Fig. 4) . However, GC cells (BGC-823) used as xenograft controls were able to form tumors 2 weeks after transplantation. Tumor formation was followed for 4 weeks.
Differentiation potential of hGC-MSCs and hGCOM-MSCs.
In addition to their colony-forming ability and the expression of specific antigens on their cell surfaces, the capacity for tri-lineage differentiation is a key property of MSCs (27) . The differentiation potential was evaluated by culturing the cells in osteogenic media. Long-term cultures (3 weeks) of cells grown in the presence of osteogenic media demonstrated the capacity to form Alizarin Red-positive condensed nodules with high levels of calcium covering the entire wells. The deposits were sparsely scattered throughout the adherent layer as single mineralized zones (Fig. 5A) .
In addition, the expression levels of ALP, OPN, OSC and DMP-1 genes, considered to be osteo-specific genes, were analyzed at the mRNA level after 3 weeks of osteoinduction. The expression of these mRNAs (relative to Actb) in differentiated hGC-MSCs and hGCOM-MSCs was higher than that in undifferentiated hGC-MSCs and hGCOM-MSCs (Fig. 5B) . These results indicate that hGC-MSCs and hGCOM-MSCs cultured in osteogenic media can differentiate into osteoblast-like cells.
Discussion
MSCs are a subset of non-hematopoietic adult stem cells that originate from the mesoderm. They possess self-renewal ability and exhibit multilineage differentiation into not only mesoderm-lineages, including chondrocytes, osteocytes and adipocytes, but also ectodermal cells and endodermal cells (28) . MSCs exist in almost all tissues. They can be easily isolated from the bone marrow, adipose tissue, umbilical cord, fetal liver, muscle and lung, and can be successfully expanded in vitro (29) . Due to a lack of specific markers to define MSCs, their identification depends on their ability to adhere rapidly to tissue culture plastic, a panel of surface markers, including CD31, CD34, CD45, CD29, CD90 and CD105, as well as showing multilineage differentiation potential. The complexity of MSC interaction with the tumor microenvironment means that tumor growth and tumor metastasis can be affected by MSCs, directly or indirectly (30) .
MSCs also exist in almost all tissues [needs citation]. Although it is hypothesized that bone marrow functions as a reservoir for disseminated tumor cells and that metastasis to secondary organs occurs due to the recirculation of disseminated tumor cells from bone marrow, the precise mechanisms remain to be elucidated. It was reported that in brain tumors affecting adult patients, tumor cells with stem-like characteristics have only been isolated from high-grade gliomas (31) . By contrast, data from the present study demonstrated that tumor cells with stem cell-like can be isolated from GC and its ovarian metastatic tissues in the same patients (6/40). Further analysis of hGC-MSCs and hGCOM-MSCs cultures demonstrated that the isolated cells expressed a complex molecular profile that combined mesenchymal and gastric elements, suggesting a high potential of plasticity. Assessing in vivo tumorigenicity, it was verified that non self-renewing cells did not form tumors when engrafted into immunodeficient mice, whereas the three long-term self-renewing ones assessed generated tumors similar to the histological and molecular profile of the original human lesion.
Our success in derivation of self-renewing oncospheres from ovarian metastases of GC is comparable with or above the 50% average success rate. Cao et al (24) initially reported the existence of MSC-like cells that can be isolated in vitro from GC tissues. In contrast to GC cells, these cells share most of the biochemical characteristics of hBM-MSCs, but also display unique characteristics, attributable to their unique locations. Our observation suggests that the ability to derive cells with properties akin to gastric progenitors or gastric stem cells from ovarian metastases of GC could be more dependent on the absolute numbers of cells endowed with progenitor or stem properties within the cultured tumor sample, than on the optimization of culture conditions for each histological tumor sub-type. Further experiments are required to address this issue.
In order to further investigate the tumorigenicity of the isolated human gastric MSCs and ovarian metastatic MSCs, these cells were injected into nude mice and the results revealed that human gastric MSCs and ovarian metastatic MSCs were not able to form tumors even 1 month after initial injection, suggesting that human GC tissue MSCs and ovarian metastatic MSCs have not undergone transformation and are MSC-like cells but not CSCs. The long prevailing model of metastasis recognizes the importance of 'seed' and 'soil' for metastatic progression. An increasing amount of attention has focused on understanding the molecular and genetic factors that confer an intrinsic metastatic advantage to certain tumor cells. In addition, changes occurring within distant tissues, creating a 'soil' conducive for tumor invasion, have been largely neglected. Bone marrow-derived stem cells emerged as key players in initiating these early changes, creating a receptive microenvironment at designated sites for distant tumor growth and establishing the 'pre-metastatic niche' (32) . This insight into the earliest stages in the metastatic cascade revises our concept of the metastatic 'microenvironment' to include physiological cells recruited from the bone marrow. Understanding the cellular and molecular cross-talk between 'seed' and 'soil' may improve our understanding of the factors that govern 
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site-specific patterning in metastasis and the phenomenon of tumor dormancy. This may lead to therapeutic strategies to detect and prevent metastasis at its earliest inception. Human gastric MSCs and ovarian metastatic MSCs may be one of the most important components of the cancer 'niche.' On one hand, human GC MSCs may support the growth of tumor cells by cell-cell interaction. Alternatively, MSCs within human ovarian metastases of GC may contribute to the vasculature and extracellular matrix for the development of these tumor cells (33) .
To the best of our knowledge, the present study is the first to demonstrate a distinct population of benign ovarian metastases of GC cells with stem cell-like properties. Further studies on the role of these cells in the initiation, development and/or progression of ovarian metastases from GC are warranted.
